MATERA, Lina

MATERA, Lina  

Mostra records
Risultati 1 - 20 di 100 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes. 1985 PEGORARO L ;FIERRO MT ;LUSSO P ;GIOVINAZZO B ;LANINO E ;GIOVARELLI M ;MATERA L ;FOA R
A role for growth hormone and prolactin in leukaemia and lymphoma? 1998 HOOGHE R ;MERCHAV S ;GAIDANO G ;NAESSENS F ;MATERA L
Action of pituitary and lymphocyte prolactin. 1997 MATERA L
AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin. 1996 GAIDANO G ;CONTARINI M ;PASTORE C ;SAGLIO G ;MATERA L
Aliphatic aldehydes inhibit the proliferative response of human peripheral blood lymphocytes to phytohemagglutinin and alloantigens. 1987 TESSITORE L ;MATERA L ;BONELLI G ;BACCINO FM ;DIANZANI MU
An approach to simultaneous immunofluorescent and autoradiographic analysis of human normal and neoplastic blood cells. 1977 CALIGARIS F ;MARINONE C ;MASERA P ;MATERA L
Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart 2007 D' Hooghe E; Buttiglieri S; Bisignano G; Brusa D; Camussi G; Matera L
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients 2000 Bellone G; Rollino C; Borsa S; Ferrero I; Martina G; Carbone A; Mareschi K; Quarello F; Piccoli G; Emanuelli G; Matera L.
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes. 1989 MATERA L; FOA R; MASSAIA M; GIOVARELLI M; VEGLIA F; CESANO A; LUSSO P; PIAZZA A; SANTOLI D
Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation 2009 Garetto S; Sizzano F; Brusa D; Tizzani A; Malavasi F; Matera L.
Biological and molecular evidence for the production of IL-6 by human natural killer cells in culture. 1989 AVANZI GC ;CESSANO A ;BRIZZI MF ;CLARK SC ;PEGORARO L ;MATERA L
Bone marrow stroma-derived prolactin isinvolved in basal and platelet-activating factor-stimulated in vitroerythropoiesis 1997 Bellone G; Astarita P; Artusio E; Silvestri S; Mareschi K; Turletti A; Buttiglieri S; Emanuelli G; Matera L.
Cell surface markers and kinetic features in acute lymphoblastic leukaemia. 1981 CALIGARIS CAPPIO F ;NOVARINO A ;MATERA L ;GAVOSTO F
Cerebrospinal fluid and plasma concentrations of POMC-related peptides in multiple sclerosis 1992 PINESSI L; RAINERO I; DE GENNARO T; VIOLANTE A; CASSANO D; MATERA L; CESANO A
Changes in SRBC binding capacity and T-surface antigen expression on human peripheral blood lymphocytes stimulated by 12-0-tetradecanoilphorbol-13-acetate (TPA). 1983 Matera L; Foa R; Marmont F; Massaia M; Palumbo A; Pegoraro L
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. 2013 Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L
Communication of the central nervous and the immune systems. 2000 L. MATERA; DAVIS J
Contribution of dendritic cells FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies 2007 SIGNORINO E; BRUSA D; GRANATA R; MALAVASI F; FERRONE S; MATERA L
Cooperation of pitCooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. 2000 L. MATERA; M. MORI
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients 2008 Beano A; Signorino E; Evangelista A; Brusa D; Mistrangelo M; Polimeni MA; Spadi R; Donadio M; Ciuffreda L; Matera L.